Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Evaluation of the Efficacy of Hyalomatrix® in the Healing of Chronic Venous Leg Ulcers

NCT: NCT07335861 · RECRUITING

NCT IDNCT07335861
StatusRECRUITING
Start Date2026-05-14
Completion2027-01-31
SponsorNuScience Medical Biologics, LLC (INDUSTRY)
First posted
Last updated

Brief Summary

This is a randomized controlled trial evaluating the efficacy of HYALOMATRIX in conjunction with standard of care vs. standard of care alone in treating venous leg ulcers.

Frequently Asked Questions

What is Evaluation of the Efficacy of Hyalomatrix® in the Healing of Chronic Venous Leg Ulcers?

Evaluation of the Efficacy of Hyalomatrix® in the Healing of Chronic Venous Leg Ulcers is a clinical trial registered under NCT07335861. Current status: RECRUITING.

What is the status of NCT07335861?

The current status of NCT07335861 (Evaluation of the Efficacy of Hyalomatrix® in the Healing of Chronic Venous Leg Ulcers) is: RECRUITING.

When did Evaluation of the Efficacy of Hyalomatrix® in the Healing of Chronic Venous Leg Ulcers start?

Evaluation of the Efficacy of Hyalomatrix® in the Healing of Chronic Venous Leg Ulcers started on 2026-05-14.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑